132 related articles for article (PubMed ID: 6339081)
1. Target cell specificity of human natural killer (NK) cells. I. Development of an NK-resistant subline of K562.
MacDougall SL; Shustik C; Sullivan AK
Cell Immunol; 1983 Feb; 76(1):39-48. PubMed ID: 6339081
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of human natural killer recognition demonstrated by cloned effector cells and differential blocking of cytotoxicity with monoclonal antibodies.
Pawelec G; Newman W; Schwulera U; Wernet P
Cell Immunol; 1985 Apr; 92(1):31-40. PubMed ID: 3865716
[TBL] [Abstract][Full Text] [Related]
3. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
Yanovich S; Hall RE; Weinert C
Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
[TBL] [Abstract][Full Text] [Related]
4. The isolation of natural killer (NK)-resistant variants of the K562 cell line by mutagenesis and selection with antibodies which inhibit NK cell-mediated lysis.
Werkmeister JA; Triglia T; Burns GF
Cell Immunol; 1985 Apr; 92(1):123-33. PubMed ID: 3865715
[TBL] [Abstract][Full Text] [Related]
5. Variance in resistance to natural and antibody-dependent cellular cytotoxicity and to complement-mediated lysis among K562 lines.
Kimber I; Moore M; Roberts K
Int J Cancer; 1983 Aug; 32(2):219-25. PubMed ID: 6575968
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against K562 cell line accelerates killing of the target cells by large granular lymphocytes.
Park MM; Brahmi Z
Cell Immunol; 1984 Mar; 84(1):94-103. PubMed ID: 6583012
[TBL] [Abstract][Full Text] [Related]
7. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
Brahmi Z; Bray RA; Abrams SI
J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
[TBL] [Abstract][Full Text] [Related]
9. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
10. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
Zarcone D; Tilden AB; Friedman HM; Grossi CE
Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
12. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
13. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
Bridges KR; Smith BR
J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
[TBL] [Abstract][Full Text] [Related]
15. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell resistance in K-562 cell sublines.
Foster JS; Wust CJ; Lozzio CB; Bamberger EG; Ichiki AT
Int J Cancer; 1985 Mar; 35(3):343-9. PubMed ID: 3855845
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG.
Kay HD; Fagnani R; Bonnard GD
Int J Cancer; 1979 Aug; 24(2):141-50. PubMed ID: 290570
[TBL] [Abstract][Full Text] [Related]
18. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
19. Studies on the susceptibility to NK-mediated lysis and the simultaneous expression of various surface molecules in anthracyclin-treated K562 cells and in four K562 cell clones.
Benoist H; Joly P; Broglio C; Jeannesson P; Idoine O; Dufer J; Desplaces A
Immunol Lett; 1992 Sep; 34(1):45-55. PubMed ID: 1362185
[TBL] [Abstract][Full Text] [Related]
20. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
